Overview

Our History

Leadership Team

Partner

Portfolio Advisory Board

Peer Reviewed Publications

Announcements and Circulars

Listing Documents

Investor Presentation

IR Contact

Investor Calendar

Stock Information (2552.HK)

Corporate Communications

Investor Relations

> Investor Relations

> Announcements and Circulars

Investor Center

Corporate Governance

Financial Report

Announcements and Circulars

Listing Documents

Investor Presentation

IR Contact

Investor Calendar

Stock Information (2552.HK)

Corporate Communications

Announcements and Circulars

Jan 07, 2025

Monthly Return

Dec 31, 2024

BUSINESS UPDATE IN RELATION TO HUATANGNING INSIDE INFORMATION

Dec 05, 2024

Monthly Return

Nov 22, 2024

BUSINESS UPDATE IN RELATION TO HUATANGNING INSIDE INFORMATION

NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REQUEST FORM

Sep 26, 2024

NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM

Sep 04, 2024

Monthly Return

Aug 29, 2024

INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024

Aug 19, 2024

Date of Board Meeting

Aug 05, 2024

Monthly Return

About Us

Overview

Our History

Leadership Team

Portfolio Advisory Board

Partner

Media center

Research & Development

Inovation

Dorzagliatin

mGluR5

Presentations

Peer Reviewed Publications

Media

Company News

Media Releases

Video

Investor Relations

Corporate Governance

Financial Report

Announcements & Circulars

Listing Documents

Investor Presentation

IR Contact

Investor Calendar

Stock information

Careers

Culture

Join Us

Products&Pipeline

Pipeline

HuaTangNing(华堂宁®)

Focus Us

沪公网安备 31011502013809号 Privacy Statement Terms of Use

How we use cookies

Hua Medicine uses cookies to enable and improve the use of the website. By continuing to use the site, you consent to the use of these cookies. To learn more about cookies, please read our privacy statement.